SIRT1 inactivation evokes antitumor activities in NSCLC through the tumor suppressor p27.
about
Power Frequency Magnetic Fields Affect the p38 MAPK-Mediated Regulation of NB69 Cell Proliferation Implication of Free RadicalsLong Non-coding RNA Growth Arrest-specific Transcript 5 (GAS5) Inhibits Liver Fibrogenesis through a Mechanism of Competing Endogenous RNA.Screening SIRT1 Activators from Medicinal Plants as Bioactive Compounds against Oxidative Damage in Mitochondrial Function.SIRT 1 Overexpression is Associated with Metastasis of Pancreatic Ductal Adenocarcinoma (PDAC) and Promotes Migration and Growth of PDAC Cells.SIRT6 delays cellular senescence by promoting p27Kip1 ubiquitin-proteasome degradation.Sirt1 regulates glial progenitor proliferation and regeneration in white matter after neonatal brain injury.HTP Nutraceutical Screening for Histone Deacetylase Inhibitors and Effects of HDACis on Tumor-suppressing miRNAs by Trichostatin A and Grapeseed (Vitis vinifera) in HeLa cellsSIRT1 promotes metastasis of human osteosarcoma cells.SIRT1 activates the expression of fetal hemoglobin genesSIRT1 controls cell proliferation by regulating contact inhibition.Interferon-γ-induced p27KIP1 binds to and targets MYC for proteasome-mediated degradation.MYC Modulation around the CDK2/p27/SKP2 AxisPrognostic and clinicopathological significance of SIRT1 expression in NSCLC: a meta-analysis.Chronic exposure to low dose of bisphenol A impacts on the first round of spermatogenesis via SIRT1 modulation.SIRT1 overexpression is an independent prognosticator for patients with esophageal squamous cell carcinoma.A novel long non-coding RNA-PRLB acts as a tumor promoter through regulating miR-4766-5p/SIRT1 axis in breast cancer.Associations of sirtuins with clinicopathological parameters and prognosis in non-small cell lung cancer
P2860
Q28393310-9A7907D3-7DEF-4D27-9564-565F35D20799Q36301298-EB8F2C26-DE81-47BD-A5CC-CA3C0C5B2AD0Q36615396-B2BEC01E-696D-492F-AC2B-F2B3A48CFFC9Q37029449-6996E48F-9516-4A45-9DDE-73358F9C94A2Q37423517-19DCC718-048A-4880-8833-E6E1459EC65AQ37533313-CDE5E2C1-E04A-418D-ACEB-E1C8D54CEEE8Q37607905-DB33E1D4-9B33-4B51-8237-BF8E763E615EQ37694826-04039D54-C8CD-4CAE-BCD7-BF7CEF59F9DFQ38641406-49A50929-C514-43F7-A112-A4D94D822242Q38752417-6EE4292A-3523-40D3-B60A-45B0AC49812EQ38809298-24FF9632-6A8C-41E0-85D8-FA5D4FF5F2A1Q39406924-9ABC554C-E149-4052-A7AD-4E9BA322B378Q41895999-FC532569-AD52-4DDE-AA1C-E496AFD128A6Q49246271-BFD361EC-4273-4DAF-879C-F10923E3D697Q52595653-1593B7ED-EE00-4449-9E7A-0C1372690571Q55048850-A629A23D-C1A3-41F2-92EB-C0D68AB812CDQ58754540-420EB430-FBB6-42EB-B239-937DE821AE9A
P2860
SIRT1 inactivation evokes antitumor activities in NSCLC through the tumor suppressor p27.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
SIRT1 inactivation evokes antitumor activities in NSCLC through the tumor suppressor p27.
@ast
SIRT1 inactivation evokes antitumor activities in NSCLC through the tumor suppressor p27.
@en
type
label
SIRT1 inactivation evokes antitumor activities in NSCLC through the tumor suppressor p27.
@ast
SIRT1 inactivation evokes antitumor activities in NSCLC through the tumor suppressor p27.
@en
prefLabel
SIRT1 inactivation evokes antitumor activities in NSCLC through the tumor suppressor p27.
@ast
SIRT1 inactivation evokes antitumor activities in NSCLC through the tumor suppressor p27.
@en
P2093
P2860
P1476
SIRT1 inactivation evokes antitumor activities in NSCLC through the tumor suppressor p27.
@en
P2093
Alexander J Stankiewicz
Christine Y Chiao
Douglas V Faller
Katelyn G Enzer
P2860
P356
10.1158/1541-7786.MCR-14-0239
P577
2014-08-20T00:00:00Z